Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

158.86
+2.621.68%
Post-market: 160.001.14+0.72%19:41 EDT
Volume:1.18M
Turnover:187.89M
Market Cap:303.10B
PE:24.02
High:159.72
Open:156.17
Low:156.10
Close:156.24
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:0.73
T/O Rate:0.06%
Dividend:4.67
Dividend Rate:2.94%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:7.30
PE(LYR):22.22

Loading ...

Can AI Make Better Drugs? not on Wall Street's Timeline

Dow Jones
·
Jul 12

Movement Alert|Novartis Falls 4.48% in After-Hours Trading, China Procurement Forgery Scandal and Aggressive M&A Spree Weigh on Shares

Market Focus
·
Jul 08

Dow Jones Top Company Headlines at 1 PM ET: Lockheed Martin to Acquire Ultra Maritime in $3.45 Billion Deal | Microsoft ...

Dow Jones
·
Jul 07

Movement Alert|Novartis Falls 3.05% in Regular Trading, $1.5 Billion Myricx Bio Acquisition Triggers Selling Pressure

Market Focus
·
Jul 06

Sector Update: Healthcare

MT Newswires Live
·
Jul 06

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Monday as Chip Stocks Rebound

MT Newswires Live
·
Jul 06

Dow Jones Top Company Headlines at 7 am ET: Michael Saylor's Strategy is Trapped by Its Own Broken Bitcoin Math | Easyjet ...

Dow Jones
·
Jul 06

Novartis agrees to acquire Myricx Bio for up to $1.5B

TIPRANKS
·
Jul 06

Novartis Bolsters Oncology Pipeline with $1.5 Billion Acquisition of Myricx Bio

Stock News
·
Jul 06

Novartis's Myricx Bio Upfront Payment Looks High

Dow Jones
·
Jul 06

Movement Alert|Novartis Rises 3.01% in Regular Trading, Spinal Muscular Atrophy Gene Therapy Wins EU Approval

Market Focus
·
Jul 02

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday Amid Latest Economic Reports

MT Newswires Live
·
Jul 02

Novartis Wins European Approval For Spinal Muscular Atrophy Gene Therapy

MT Newswires Live
·
Jul 02

Novartis, Antares Therapeutics Sign Oncology Drug Discovery Deal Worth Up to $1.9 Billion

MT Newswires Live
·
Jun 24

Movement Alert|Novartis Rises 3.01% in Regular Trading, Antibody-Conjugated Oligonucleotide Drug Delivers Positive Early Clinical Data

Market Focus
·
Jun 24

Switzerland Voted Against a Population Cap but This Isn't the Last We'll Hear About It -- Barrons.com

Dow Jones
·
Jun 19

Novartis' Rhapsido Meets Primary Endpoints in Chronic Inducible Urticaria Trial

MT Newswires Live
·
Jun 12

Analysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (LLY), Insulet (PODD) and Novartis (NVS)

TIPRANKS
·
Jun 12

Sector Update: Healthcare Stocks Rise Thursday Afternoon

MT Newswires Live
·
Jun 12

Movement Alert|Novartis Rises 3.11% in Pre-Market Trading, Multiple Pipeline Catalysts Drive Positive Sentiment

Market Focus
·
Jun 11